Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01978405
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01978405
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01978405. Randomized; single masking; primary purpose prevention. Start 2013-11 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
- Condition
- Acute Kidney Injury
- Condition
- The Changes of Plasma Creatinine
- Condition
- The Changes of Plasma Free Radicals
- Condition
- The Changes of Endothelium-dependent Arterial Dilation
- Intervention (Drug)
- Alpha lipoic acid
- Lead sponsor
- Xiang Guang-da
Record details
- Record id
cardio:ct-nct01978405- Content hash
ed0172114b2519eb9511d8b4a44262ceeb596a455128b24f79ed759c8927c4c9